Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–13 of 13 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06792552
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +35 more
- Locations
-
- Sarah Cannon Research Institute (SCRI) - Lake Nona Orlando, Florida, United States
- Emory Winship Cancer Institute Atlanta, Georgia, United States
- University Medical Center of New Orleans LSU-LCMC Health Cancer Center New Orleans, Louisiana, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT07444814
- Conditions
- Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
- Locations
-
- University of Arkansas Little Rock, Arkansas, United States
- UCLA - Hematology/Oncology Clinical Research Unit Los Angeles, California, United States
- St. Francis Medical Center (OSF Healthcare) Peoria, Illinois, United States
- START - Midwest Grand Rapids, Michigan, United States
NCT07470853
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
- Locations
-
- University of Arkansas - Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
- START - Los Angeles Los Angeles, California, United States
- SCRI - Florida Cancer Specialists Sarasota, Florida, United States
- St. Francis Medical Center (OSF Healthcare) Peoria, Illinois, United States
Recruiting
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
NCT07030907
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- Karmanos Cancer Institute Detroit, Michigan, United States
- University of Minnesota Minneapolis, Minnesota, United States
- Roswell Park Buffalo, New York, United States
- MD Anderson Cancer Center Houston, Texas, United States
Not Yet Recruiting
A Phase 1 Study to Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
NCT07664735
- Conditions
- Adnexal Diseases, Advanced Endometrial Cancer, Endocrine Gland Neoplasms, +22 more
- Locations
-
Not specified
Not Yet Recruiting
Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer
NCT07265739
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +19 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Not Yet Recruiting
Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer
NCT07117877
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer
NCT06973421
- Conditions
- Platinum Resistant Ovarian Cancer
- Locations
-
- Fudan University Shanghai Cancer Cente Shanghai, Shanghai Municipality, China
NCT03552471
- Conditions
- Adnexal Diseases, BRCA1 Gene Mutation, BRCA2 Gene Mutation, +24 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT06517485
- Conditions
- Non-Small Cell Adenocarcinoma, Platinum Resistant Ovarian Cancer
- Locations
-
- University of Oklahoma Oklahoma City, Oklahoma, United States
NCT06517433
- Conditions
- Non Small Cell Lung Cancer Metastatic, Platinum Resistant Ovarian Cancer
- Locations
-
- University of Oklahoma Oklahoma City, Oklahoma, United States
Completed
A Phase I/II Trial of VB-111 and Paclitaxel for Recurrent Platinum-Resistant Müllerian Cancer
NCT01711970
- Conditions
- Platinum Resistant Ovarian Cancer
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Active, Not Recruiting
First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b
NCT03319628
- Conditions
- Non Small Cell Lung Cancer Metastatic, Platinum Resistant Ovarian Cancer
- Locations
-
- University of Oklahoma Oklahoma City, Oklahoma, United States